Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Difficulty in standing; Hand and foot numbness; Palpitations; This is a spontaneous report from a contactable physician received from the The regulatory authority; report number is v21111925. The patient was a 37-year-old female. The patient was allergy to the local anesthetics and caffeine. Body temperature before the vaccination was 36.2 degrees Centigrade. On the 03Jun2021 at 9:10 A.M. (the day of the vaccination) the patient received BNT162B2(COMIRNATY, Solution for injection, Lot number: EY0779, Expiration date: 31Aug2021) via an unspecified route of administration, as 1st dose, single for COVID-19 immunization. The course of the event was as follows: The event onset date was as reported as 04Jun2021 (the day after the vaccination). At 15:00 of 04Jun2021, the patient developed hand and foot numbness, palpitations, and difficulty in standing. At the request of the patient''s family, the patient was rushed to the hospital. The outcome of the events was recovering at 04Jun2021. The reporter classified the events as serious (can lead to disability) and assessed that that the causality between the BNT162B2 was not provided. The reporting physician commented as follows: It was contacted the patient that night and learned that the patient''s symptoms had improved, returned home.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166